Case File
efta-efta00710815DOJ Data Set 9OtherFrom: Paul S Barrett
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00710815
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Paul S Barrett
To: Jeffrey Epstein <jeevacation@gmail.com>
Subject: RE: Oil
Date: Thu, 09 Dec 2010 16:34:56 +0000
oil option now bid at $45,000
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
From: Jeffrey Epstein [rnailto:jeevacation@gmall.com]
Sent: Thursday, December 09, 2010 11:31 AM
To: Paul S Barrett
Subject: Re: Oil
should i have watched mysetill this is ridiculous
On Thu, Dec 9, 2010 at 11:30AM, Paul S Barrett <
> wrote:
530,000 - S119,000
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
From: Jeffrey Epstein [mailto:jecvacation®gmail.com]
Sent: Thursday, December 09, 2010 11:27 AM
To: Paul S Barrett
Subject: Re: Oil
no the range of the calls
On Thu, Dec 9, 2010 at 11:25 AM, Paul S Barrett <
> wrote:
90.85 on the 7th of Dec
Range has been 80 - 90.85 over the past 30days
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
EFTA00710815
From: Jeffrey Epstein [mailtojeevacation®
ail com
Sent: Thursday, December 09, 2010 11:23 AM
To: Paul S Barrett
Subject: Re: Oil
how high did it get in the past two weeks„
On Thu, Dec 9, 2010 at 11:06 AM, Paul S Barrett <
> wrote:
We can sell the 90 oil call that expires next week for 30,000. Was cashless upfront.
New risk reversal would be:
Aug2011 contract
100 Call
81.25 Put
Or
105 Call
77.25 Put
Both cashless
I like the 1st strategy
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://wwwjpmorgan.corn/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
EFTA00710816
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments.
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://www.jpmorgan.corn/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com, and
destroy this communication and all copies thereof,
including all attachments.
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://svww.jpmorgan.corn/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments.
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email.
EFTA00710817
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
jeevacation@gmail.comEmail
jeevacation@gmall.comURL
http://svww.jpmorgan.corn/pages/disclosures/emailURL
http://www.jpmorgan.com/pages/disclosures/emailURL
http://www.jpmorgan.corn/pages/disclosures/emailURL
http://wwwjpmorgan.corn/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.